Most US neurologists treating patients with multiple sclerosis receive industry payments, with higher payments linked to higher prescribing of that company’s drugs, new research shows.

Multiple sclerosis (MS) is a chronic neurological disorder characterized by a wide array of symptoms that can vary in severity and manifestation. While the ...

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under ...

From isolation to community: How UAE's MS support network grows MS is a lifelong neurological condition in which the immune system mistakenly attacks myelin—the protective sheath that covers nerve ...

Patient preference studies (research into what patients value in their treatment) are increasingly used to inform drug ...

Scientific study conducted in collaboration with the National Multiple Sclerosis Society Abu Dhabi: In a landmark regulatory achievement that reflects the UAE’s leadership in accelerating access to ...

Snapped returns to a 1996 Peoria, Arizona stabbing that began inside an assisted living apartment and ended with four arrests ...

In a landmark regulatory achievement that reflects the UAE’s leadership in accelerating access to innovative therapies, the Emirates Drug Establishment has announced the approval of “Tolebrutinib” as ...

The UAE has approved Tolebrutinib, the world’s first oral treatment for non-relapsing secondary progressive multiple sclerosis (SPMS). Developed to slow disability progression without relying on ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...